Linda Chamberlain leads the GVSU Technology Commercialization Office in advancing the research and innovations of faculty, students and staff.  This work highly leverages Dr. Chamberlain’s 25+ year career in innovation, new product development and launch implementation.  Dr. Chamberlain has led strategic business and product development at Fortune 200, mid-sized and start-up companies, including Shell Chemical, Honeywell, and Johnson Controls.  Linda developed a keen sense of venture capital investing through her role as Director with the Michigan Accelerator Fund, and as CEO of NanoRETE, a grant funded start-up delivering new diagnostic technology for tuberculosis. Prior to this, she led global strategy and product commercialization for Global Forex Trading, which was acquired in 2012 for >$100M.  Linda, as Executive Director, led the West Michigan Science and Technology Initiative, a business accelerator focused on commercialization of life science products and technologies, as well as led the relaunch of GVSU’s Center for Entrepreneurship and Innovation.  She is owner and principal of InnoValuation®, a company that focuses on insuring companies have the processes and performance to extract the full value from their innovations.  Dr. Chamberlain received both her BS and PhD in Chemistry from Purdue University, and has 19 patents issued for catalyst, polymer, and product/process development. Dr. Chamberlain is serving on the boards of Paragon Die & Engineering and Frederik Meijer Gardens. 

If you have any further questions please contact Linda Chamberlain at: [email protected]